Catheters and Active Implantable CDMO Market Research Report Information By Service Category (Catheters, Active Implantable Devices, Endoscopy Devices, and Others), By End-Users (Medical Device OEM Companies, Academic and Research Institutes, and Government Agencies) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032
Overview of the Market
In 2023, the market for active implantable CDMOs and catheters was estimated to be worth USD 6.92 billion. With a compound annual growth rate (CAGR) of 10.82% from 2024 to 2032, the sector is expected to increase from USD 7.49 billion in 2024 to USD 18.8 billion by 2032.
The market is growing because of more manufacturing outsourcing and growing strategic initiatives related to catheters and active implantable CDMO.
The global market for catheters and active implanted CDMOs is expanding significantly because of growing initiatives that are fostering innovation and enhancing market accessibility. Strategic mergers and acquisitions enable companies to offer comprehensive solutions and accelerate product development by combining resources and expertise. At the same time, increased investments in healthcare infrastructure, especially in emerging nations, and a growing need for minimally invasive procedures are driving up the usage of advanced catheters and implantable devices.
Perspectives on Market Segments
The Catheters and Active Implantable CDMO Market has been divided into three segments based on the service segment: endoscopy devices, active implantable devices, and catheters.
The Catheters and Active Implantable CDMO Market is divided into government organizations, academic and research institutions, and medical device OEM firms based on the end user.
Regional Perspectives
In 2023, North America held the biggest market share, which it is expected to maintain throughout the forecast period. Nonetheless, over the course of the forecast period, Asia-Pacific is anticipated to develop at the greatest CAGR.
The market for active implantable CDMOs in North America is expanding rapidly due to a favorable regulatory environment, growing healthcare demands, and technology breakthroughs. Furthermore, the market is driven by advanced healthcare infrastructure and significant research & development spending that makes it possible to create innovative implantable devices. Additionally, there are growth prospects due to the rise of customized treatment, the need for minimally invasive solutions, and prospects for expansion into new countries.
Europe, which is further divided into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe, comes after the Americas. The market for active implantable CDMOs in Europe has a lot of room to grow thanks to increased healthcare demands and technology developments. The need for specialized manufacturing knowledge is being driven by technological improvements in implantable devices, including insulin pumps, neurostimulators, and next-generation cardiac pacemakers. The need for advanced, superior implanted solutions is further increased by the aging population and the rising incidence of chronic diseases.
Over the course of the forecast period, Asia-Pacific is anticipated to expand at the fastest rate and see substantial expansion due to several important variables. The need for advanced implantable devices is being driven by the quick development of medical technology and rising investments in healthcare infrastructure in nations like China, India, and Japan. The need for creative solutions is further fueled by the aging population, diabetes, and the increasing prevalence of chronic diseases.
Key Players
Integer Holdings Corporation (US), Cirtec (US), Biomerics (US), Switchback Medical (US), Velentium LLC (US), Heraeus Group (Germany), Zeus Company LLC (US), Veranex (US), Freudenberg Medical (US), and Medeologix (Taiwan) are the leading companies in the catheter and active implantable CDMO market.
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 1 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 2 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY REGION, 2018–2032 (USD MILLION)
TABLE 3 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 4 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CARDIAC CATHETERS, BY REGION, 2018–2032 (USD MILLION)
TABLE 5 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR UROLOGY CATHETERS, BY REGION, 2018–2032 (USD MILLION)
TABLE 6 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROVASCULAR CATHETERS, BY REGION, 2018–2032 (USD MILLION)
TABLE 7 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018–2032 (USD MILLION)
TABLE 8 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY REGION, 2018–2032 (USD MILLION)
TABLE 9 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 10 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY REGION, 2018–2032 (USD MILLION)
TABLE 11 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 12 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR SPINAL CORD STIMULATORS, BY REGION, 2018–2032 (USD MILLION)
TABLE 13 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR DEEP BRAIN STIMULATORS, BY REGION, 2018–2032 (USD MILLION)
TABLE 14 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018–2032 (USD MILLION)
TABLE 15 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY REGION, 2018–2032 (USD MILLION)
TABLE 16 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 17 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR VALVE IMPLANTS, BY REGION, 2018–2032 (USD MILLION)
TABLE 18 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STENTS & SHUNTS, BY REGION, 2018–2032 (USD MILLION)
TABLE 19 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018–2032 (USD MILLION)
TABLE 20 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY REGION, 2018–2032 (USD MILLION)
TABLE 21 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 22 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR PERCUTANEOUS LEFT VENTRICULAR ASSIST DEVICE (LVAD), BY REGION, 2018–2032 (USD MILLION)
TABLE 23 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR PERCUTANEOUS RIGHT VENTRICULAR SUPPORT DEVICES (RVAD), BY REGION, 2018–2032 (USD MILLION)
TABLE 24 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018–2032 (USD MILLION)
TABLE 25 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR UROLOGY IMPLANTABLE DEVICES, BY REGION, 2018–2032 (USD MILLION)
TABLE 26 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018–2032 (USD MILLION)
TABLE 27 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ENDOSCOPY DEVICES, BY REGION, 2018–2032 (USD MILLION)
TABLE 28 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018–2032 (USD MILLION)
TABLE 29 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 30 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR MEDICAL DEVICE OEM COMPANIES, BY REGION, 2018–2032 (USD MILLION)
TABLE 31 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018–2032 (USD MILLION)
TABLE 32 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR GOVERNMENT AGENCIES, BY REGION, 2018–2032 (USD MILLION)
TABLE 33 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY REGION, 2019–2032 (USD MILLION)
TABLE 34 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018–2032 (USD MILLION)
TABLE 35 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 36 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 37 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 38 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 39 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 40 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 41 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 42 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 43 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 44 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 45 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 46 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 47 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 48 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 49 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 50 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 51 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 52 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 53 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 54 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 55 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 56 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018–2032 (USD MILLION)
TABLE 57 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 58 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 59 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 60 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 61 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 62 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 63 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 64 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 65 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 66 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 67 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 68 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 69 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 70 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 71 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 72 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 73 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 74 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 75 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 76 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 77 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 78 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 79 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 80 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 81 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 82 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 83 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 84 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 85 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 86 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 87 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 88 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 89 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 90 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 91 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 92 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 93 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 94 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 95 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 96 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 97 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 98 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 99 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 100 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 101 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 102 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 103 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 104 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 105 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 106 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018–2032 (USD MILLION)
TABLE 107 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 108 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 109 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 110 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 111 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 112 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 113 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 114 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 115 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 116 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 117 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 118 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 119 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 120 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 121 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 122 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 123 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 124 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 125 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 126 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 127 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 128 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 129 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 130 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 131 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 132 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 133 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 134 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 135 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 136 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 137 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 138 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 139 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 140 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 141 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 142 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 143 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 144 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 145 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 146 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 147 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 148 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 149 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 150 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 151 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 152 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 153 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 154 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 155 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 156 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018–2032 (USD MILLION)
TABLE 157 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 158 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 159 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 160 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 161 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 162 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 163 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 164 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 165 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 166 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 167 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 168 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 169 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 170 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 171 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018–2032 (USD MILLION)
TABLE 172 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018–2032 (USD MILLION)
TABLE 173 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 174 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 175 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 176 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018–2032 (USD MILLION)
TABLE 177 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018–2032 (USD MILLION)
TABLE 178 FACILITY EXPANSION
TABLE 179 ACQUISITION
TABLE 180 PARTNERSHIP
TABLE 181 INTEGER HOLDINGS CORPORATION: PRODUCT OFFERED
TABLE 182 INTEGER HOLDINGS CORPORATION: KEY DEVELOPMENTS
TABLE 183 CIRTEC: PRODUCTS OFFERED
TABLE 184 CIRTEC: KEY DEVELOPMENTS
TABLE 185 BIOMERICS: PRODUCTS OFFERED
TABLE 186 BIOMERICS: KEY DEVELOPMENTS
TABLE 187 SWITCHBACK MEDICAL: PRODUCTS OFFERED
TABLE 188 VELENTIUM LLC: PRODUCTS OFFERED
TABLE 189 HERAEUS GROUP: PRODUCTS OFFERED
TABLE 190 ZEUS COMPANY LLC: PRODUCTS OFFERED
TABLE 191 VERANEX: PRODUCTS OFFERED
TABLE 192 FREUDENBERG MEDICAL: PRODUCTS OFFERED
TABLE 193 MEDEOLOGIX: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET: STRUCTURE
FIGURE 2 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET
FIGURE 6 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, SERVICE CATEGORY, 2023 & 2032 (USD MILLION)
FIGURE 7 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2023 & 2032 (USD MILLION)
FIGURE 8 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY SERVICE CATEGORY, 2023
FIGURE 9 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, END USER, 2023 & 2032 (USD MILLION)
FIGURE 10 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 11 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY END USER, 2023
FIGURE 12 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 13 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY REGION, 2023
FIGURE 14 NORTH AMERICA MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2018-2032
FIGURE 15 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 16 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 17 EUROPE MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2018-2032 (USD MILLION)
FIGURE 18 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 19 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 20 ASIA-PACIFIC MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2019-2032 (USD MILLION)
FIGURE 21 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 22 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 23 REST OF THE WORLD MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2018-2032 (USD MILLION)
FIGURE 24 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 25 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 26 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023
FIGURE 27 COMPETITOR DASHBOARD: GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET
FIGURE 28 INTEGER HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 INTEGER HOLDINGS CORPORATION: SWOT ANALYSIS
FIGURE 30 CIRTEC: SWOT ANALYSIS
FIGURE 31 SWITCHBACK MEDICAL: SWOT ANALYSIS
FIGURE 32 HERAEUS GROUP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 HERAEUS GROUP: SWOT ANALYSIS
FIGURE 34 ZEUS COMPANY LLC: SWOT ANALYSIS
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們